Capital Performance Advisors’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $57.7K | Sell |
|
|||||
|
2025
Q2 | $38.4K | Hold |
|
|||||
|
2025
Q1 | $66.5K | Hold |
|
|||||
|
2024
Q4 | $48.8K | Hold |
|
|||||
|
2024
Q3 | $26.5K | Sell |
|
|||||
|
2024
Q2 | $31.3K | Buy |
|
|||||
|
2024
Q1 | $33.1K | Buy |
|
|||||
|
2023
Q4 | $46.2K | Buy |
|
|||||
|
2023
Q3 | $43.1K | Hold |
|
|||||
|
2023
Q2 | $51.9K | Hold |
|
|||||
|
2023
Q1 | $54.5K | Hold |
|
|||||
|
2022
Q4 | $35.6K | Hold |
|
|||||
|
2022
Q3 | $27K | Hold |
|
|||||
|
2022
Q2 | $28K | Buy |
|